ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 59 filers reported holding ODONATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $298,000 | -93.9% | 102,409 | -59.9% | 0.00% | -95.3% |
| Q4 2020 | $4,900,000 | +373.4% | 255,202 | +231.3% | 0.04% | +290.9% |
| Q3 2020 | $1,035,000 | -54.6% | 77,033 | +42.9% | 0.01% | -56.0% |
| Q2 2020 | $2,282,000 | +227.4% | 53,904 | +113.4% | 0.02% | +177.8% |
| Q1 2020 | $697,000 | -49.9% | 25,258 | -33.4% | 0.01% | -52.6% |
| Q2 2019 | $1,391,000 | +56.8% | 37,923 | -5.5% | 0.02% | +46.2% |
| Q1 2019 | $887,000 | – | 40,117 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $54,146,000 | 10.78% |
| Boxer Capital, LLC | 5,607,086 | $19,569,000 | 0.69% |
| Ikarian Capital, LLC | 1,986,412 | $6,933,000 | 0.56% |
| Samsara BioCapital, LLC | 700,421 | $2,444,000 | 0.30% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 186,680 | $652,000 | 0.29% |
| EcoR1 Capital, LLC | 831,200 | $2,901,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 113,360 | $396,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 230,794 | $805,000 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 41,210 | $144,000 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 81,180 | $283,000 | 0.02% |